Background: Epithelial cells affected by somatic mutations undergo transition from a tumoursuppressive to a carcinogenic Smad pathway during sporadic colorectal carcinogenesis, and the specific linker threonine phosphorylation of Smad2/3 in colon epithelial cells indicates stem-like cells. This study extends previous observations to a model of colitis-associated colorectal cancer. Methods: After Crl:CD-1 mice received an administration of azoxymethane [AOM], the mice were given dextran sodium sulfate [DSS] for 7 days. AOM/DSS-treated mice [AOM/DSS mice] were killed at 10 or 20 weeks. After macroscopic observations, a histopathological analysis was conducted. Immunohistochemical staining was performed using the avidin-biotin immunoperoxidase method [pSmad3C-Ser, pSmad3L-Ser, c-Myc] and immunofluorescent methods [Ki67, β-catenin, CDK4, cyclin D1, Sox9, pSmad2/3L-Thr]. Results: The colons from AOM/DSS mice were shorter than those from control mice. The number of colon tumours at Week 20 was higher than at Week 10. The inflammation scores for AOM/DSS mice were greater than those for control mice. Immunostaining-positive cells (staining by Ki67, β-catenin [nuclear and cytoplasmic], cyclin D1, and Sox9) were diffusely distributed in colon tumours. The percentage of pSmad3L-Ser-positive cells in colon tumours was higher than in sites of pre-neoplastic colitis, and that in sites of pre-neoplastic colitis was higher than in control mice. pSmad2/3L-Thr-positive cells were sparsely detected around crypt bases in non-neoplastic colon epithelia and at the tops of tumours, and immunohistochemical co-localisation of pSmad2/3L-Thr with Ki67 was not observed. Immunohistochemical co-localisation of pSmad2/3L-Thr with β-catenin and CDK4 was observed. Conclusions: pSmad3L-Ser signalling is an early event in colitis-associated colorectal cancer, and pSmad2/3L-Thr immunostaining-positive cells might be cancer stem cells.
Introduction
Patients with ulcerative colitis [UC] are at increased risk for developing colorectal cancer [CRC] . 1 The prevalence of UC-associated CRC has steadily increased worldwide. 2 To date, the pathogenesis of UC-associated CRC remains unclear. It is suspected that chronic inflammation is the cause of carcinoma, a hypothesis supported by clinical evidence that shows CRC risk increases with a longer duration and wider anatomical extent of UC. 3 Additionally, certain drugs used to reduce inflammation may prevent the development of CRC. 4 The major carcinogenic pathways that lead to sporadic CRC, namely chromosomal instability, microsatellite instability, and hypermethylation, also occur in UC-associated CRC. 5, 6, 7 There have been various attempts to investigate the pathogenesis of UC-associated CRC using animal models. Dextran sodium sulfate [DSS] has been the most widely used chemical to induce colitis. 8 The DSS animal model is also available for examining UC-associated CRC. Intestinal tumours in rats fed 5 % DSS developed between 134 and 215 days. 9 Cooper et al. reported a relationship between the severity of DSS-induced inflammation and colorectal carcinogenesis similar to human UC-associated CRC histopathology. 10 However, these studies require a long experimental period or repeated administration of DSS. 10, 11, 12 One previous study demonstrated that treatment with DSS enhances the development of putative precursor lesions [aberrant crypt foci] for CRC in rats. 13 Tanaka et al. proposed a novel mouse model of colitis-associated CRC, using azoxymethane [AOM] and DSS [AOM/DSS]. 14 In the AOM/DSS-treated mouse model, exposure to a single dose of AOM followed by 1-week treatment with 2% DSS could induce a number of CRCs within 20 weeks. Moreover, the first CRC was found as early as 6 weeks after administration of AOM. 15 Recently, cancer stem cell [CSC] theory has emerged as an attractive hypothesis for cancer development and progression. The theory suggests that cancers consist of subsets of cells with functional heterogeneity. In the CSC model, one small subset of cancer cells has the characteristics of stem cells. These CSCs have the capabilities of both self-renewal and differentiation into diverse cancer cells, and play a decisive role in maintaining capacity for malignant proliferation, invasion, metastasis, and cancer recurrence. 16, 17 Assuming CSCs are relatively resistant to the therapies developed to eradicate the non-CSC component of cancers, the CSC model provides a theoretical basis for developing therapies that target the minority CSC population and presents a new perspective for the treatment of cancer. 17 Smads, central mediators that convert signals from receptors for the transforming growth factor-β [TGF-β] 28 In our previous study, we identified significant expression of Smad2/3, phosphorylated at the specific linker threonine residues [pSmad2/3L-Thr], in murine colon epithelial cells and have suggested these cells are colon epithelial stem-like cells. 29 The antipSmad2/3L-Thr sera used in the previous study recognise the same linker phosphorylation of Smad3 as the specific phosphorylation of the Thr residue by CDK4 reported by Matsuura et al. 22, 26 During sporadic colorectal carcinogenesis, epithelial cells affected by somatic mutations such as K-ras gene mutations undergo transition from a tumour-suppressive pSmad3C-Ser pathway to a carcinogenic pSmad2/3L-Ser pathway. 30, 31 The present study extends our previous observations to a mouse model of colitis-associated CRC. This investigation of Smad2/3 phosphorylation profiles clarifies the proposition that additional carcinogenic pSmad3L-Ser signalling induced by chronic inflammation is an important early event in colitis-associated CRC. Furthermore, this study also explores whether pSmad2/3L-Thr can serve as a biomarker for CSCs of a mouse model of colitis-associated CRC.
Materials and Methods

Mice
Five-week-old male Crl:CD-1 [ICR] mice were purchased from Charles River Laboratories [Charles River Laboratories Japan, Yokohama, Japan]. All mice were bred at the Kansai Medical University animal facility under specific pathogen-free conditions. Mice were offered commercially available food pellets [F2; Funabashi Farm, Chiba, Japan] and tapwater. The Ethics Committee for the Use of Experimental Animals of Kansai Medical University approved all experimental protocols.
Chemicals
AOM, a colon carcinogen, was purchased from Sigma-Aldrich [Sigma-Aldrich Japan K.K., Tokyo, Japan]. DSS with a molecular weight of 36 000-50 000 was purchased from MP Biomedicals [MP Biomedicals, Solon, OH, USA]. DSS for induction of colitis was dissolved in water at a concentration of 2 %. Colons were flushed with saline, excised, cut open longitudinally along the main axis, and washed with saline again. The length of the colon [from the ileocecal junction to the anal verge] was measured. After macroscopic observations, they were cut and fixed in 10%-buffered formalin. Paraffin-embedded sections were made using routine procedures.
Experimental design
Histopathological analysis
Histopathological alterations were identified in haematoxylin and eosin-stained sections. Colitis was scored according to the following morphological criteria described by Cooper et al.. 32 0, normal colonic mucosa; 1, loss of one-third of the basal crypts, with mild inflammation and oedema in the mucosa; 2, loss of two-thirds of the basal crypts, with moderate inflammation in the mucosa; 3, loss of all crypts, with severe inflammation in the mucosa, but with retention of the surface epithelium; and 4, loss of all crypts and the surface epithelium, with severe inflammation in the mucosa, muscularis propria, and submucosa. Colon neoplasms were diagnosed according to the description by Ward. Thr 179] sera were raised against the phosphorylated COOHterminal and linker regions of Smad2 and Smad3 by immunising rabbits with synthetic peptides. 26, 30, 34 Relevant antisera were affinitypurified using phosphorylated peptides as previously described. 35 
Immunohistochemistry
Immunohistochemical staining was performed on formalin-fixed paraffin-embedded sections using the avidin-biotin immunoperoxidase method [pSmad3C-Ser, pSmad3L-Ser, c-Myc] and immunofluorescent method [Ki67, β-catenin, CDK4, cyclin D1, Sox9, pSmad2/3L-Thr], as described previously. 36, 37 Briefly, paraffin-embedded sections were deparaffinised and rehydrated through xylene and ethanol washes. Non-enzymatic antigen retrieval was performed by heating sections to 121°C in a 0.01 M sodium citrate buffer [ After incubation with the primary and biotin-conjugated secondary Abs using the avidin-biotin immunoperoxidase method [pSmad3C-Ser, pSmad3L-Ser, c-Myc], the sections were incubated with avidin-biotin peroxidase complex [ABC Elite Kit; Vector Laboratories, Burlingame, CA, USA]. Then, sections were reacted with a fresh mixture of 0.05% 3,3'-diaminobenzidine and 0.005% H 2 O 2 in TBS. Nuclei were counterstained with haematoxylin.
In the immunofluorescent method [Ki67, β-catenin, CDK4, cyclin D1, Sox9, pSmad2/3L-Thr], appropriate species-specific AlexaFluor Well-oriented portions from the base to the surface of the mucosa and tumour were selected for counting immunostaining-positive cells in 10 successive crypts for each colon, and results were averaged.
Statistical analysis
All values were expressed as mean (± standard error of the mean [SEM]). Data were analysed by one-way analysis of variance followed by Fisher's protected least significant difference test. A p-value of less than 0.05 was accepted as statistically significant. 
Results
Macroscopic observations
Microscopic observations
In contrast to control mice [ Figure 3a ], pre-neoplastic colitis was identified in the middle and distal colons in AOM/DSS mice at Weeks 10 [ Figure 3b Most colon tumours at Weeks 10 [ Figure 3c ] and 20 showed the characteristics of intramucosal adenocarcinoma. The nuclei were enlarged, round, or ovoid, with prominent nucleoli; nuclear polarity was almost completely lost; numerous mitoses were present; and goblet cells were completely absent. A few of them were observed to invade beyond the muscularis mucosae [ Figure. 
Immunohistochemical staining against markers involved with Smad3 phosphoisoform-mediated signalling
Immunohistochemical staining for pSmad3C-Ser uniformly showed many positive cells in each crypt in both normal mucosae from control mice [ Figure 5a ] and sites of pre-neoplastic colitis in AOM/DSS 
Discussion
UC-associated CRC is closely related to long-standing tissue injury and chronic inflammation. 2 The relationship between chronic inflammation and carcinoma dates back to Virchow, who hypothesised that the origin of carcinoma was at sites of chronic inflammation. 38 Although the relationship has been well established in general, the molecular mechanisms involved in the process remain unclear. Chronic inflammation leads to increased oxidative stress. Leukocytes and other phagocytic cells generate reactive oxygen and nitrogen species that can damage epithelial cells. Chronic inflammation also promotes the apoptosis of normal epithelial cells, which can lead to a compensatory proliferative response by the remaining tissue. In AOM/DSS mice, pre-neoplastic colitis was found persistently even 20 weeks after the AOM injection [18 weeks after the DSS administration]. Colon tumours were predominantly located in the distal colon of AOM/DSS mice, where DSS colitis was most severe. With a longer duration of the inflammation, the number of the colon tumours increased significantly. These results are consistent with characteristics of UC-associated CRC.
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Ki67 antigen is a nuclear matrix protein that is expressed in proliferating cells, but not in quiescent cells. 39 In non-neoplastic colon epithelia from control and AOM/DSS mice, Ki67-positive cells were observed around crypt bases. The zone of the crypt in which Ki67-positive cells are located is referred to as the proliferating zone. However, in neoplastic colon tumours, Ki67-positive cells were observed throughout the tumours.
β-catenin is a key component of the cadherin-mediated cell-cell adhesion system and an important molecule in the Wnt-APC signal transduction system. 40 It regulates transcription of genes related to growth, development, and differentiation of cells. Although β-catenin is detected in the cell membrane in non-neoplastic colon epithelial cells, accumulation of nuclear and cytoplasmic β-catenin is associated with colon carcinogenesis. 41 D-type cyclins have been discovered to be factors whose expression is increased by growth signals. They are considered to be mediators of signalling that link extracellular stimuli to cell-cycle machinery. 42, 43 In AOM-induced mouse colon tumour, nuclear cyclin D1 overexpression is observed. 44 In accordance with these earlier studies, we detected nuclear and cytoplasmic β-catenin accumulation and nuclear cyclin D1 overexpression in neoplastic colon tumours from AOM/DSS mice.
Sox9 is a high-mobility group box transcription factor that is expressed in the progenitor and stem cell zone of the small intestine and colon. 45, 46 In non-neoplastic colon epithelia from control and AOM/DSS mice, Sox9-positive cells were observed around crypt bases. These cells are expected to include transit-amplifying progenitor and colon epithelial stem cells. 46 In neoplastic colon tumours from AOM/DSS mice, Sox9-positive cells were diffusely observed in most of the tumour cells. Sox9 is thought to have important roles for carcinogenesis, and it is overexpressed in a wide range of human cancers including CRC where its expression is correlated with malignant character and progression. D-type cyclins form complexes with CDK4 or CDK6. These complexes phosphorylate and inactivate the retinoblastoma protein family. This process is indispensable for progression of the cell cycle from the G0-G1 transition to the S phase. 48, 49 Matsuura et al. reported that active complexes of CDK4 and D-type cyclins also phosphorylate the specific sites of Smad3 [and, presumably, homologous Smad2] and facilitate progression of the cell cycle from the G1 [or G0] to the S phase. 22, 48, 49, 50 Interestingly, the anti-pSmad2/3L-Thr sera used in the present study recognise the same linker phosphorylation of Smad3 as the specific phosphorylation of Thr residue reported by Matsuura et al. 22, 26 Moreover, Furukawa et al. reported that CD34-positive haematopoietic stem cells in the G0 phase generally suppress expression of CDKs and cyclins, except for CDK4. 51 Also in this study, immunohistochemical co-localisation of pSmad2/3L-Thr with CDK4 was observed in non-neoplastic epithelia at the crypt base. In addition, our previous studies have already demonstrated that pSmad2/3L-Thr-positive cells were BrdU label-retaining, slowcycling, and Ki67-negative quiescent cells in the G0 phase, and were located adjacent to actively proliferating cells [in the proliferating zone]. 29, 52 Taken together, CDK4 and D-type cyclins may phosphorylate Smad3 [and Smad2] at the specific linker Thr residue at the beginning of the G0-G1 transition, and these cells may transiently express more pSmad2/3L-Thr than any other cells. Therefore, we have consistently proposed that pSmad2/3L-Thr is useful for identifying stem-like cells immediately before they re-enter the cell cycle from the dormant state of the G0 phase in the oesophagus, stomach, small intestine, and colon. 29, 36, 52 According to the CSC theory, a minority of undifferentiated cancer cells, which exhibit characteristics similar to normal stem cells, drive tumour growth and spread. Although CSCs have the capacity for self-renewal, they are comparatively quiescent. They have proliferative capacity but are often not cycling. They have been shown to have significantly longer cell-cycle times than proliferating non-CSCs. This is presumably due to the arrest of CSCs at the G0 phase. 53 Although CRC has been intensively studied, the cell of origin for cancer formation is still poorly understood. Two possible hypotheses have been suggested: the bottom-up and top-down theories. The bottom-up theory proposes that a normal stem cell is the first transformed cell, giving rise directly to cancer cells or reprogramming itself and acquiring CSC behaviour before inducing cancer. 54, 55, 56 However, histological evidence suggests the top-down model of CRC development, in which CRC might arise from late progenitors or even an early differentiated cell.
The top-down model is supported by the finding that dysplastic cells are routinely found at the luminal surface of the crypts, whereas the cells at the bases of these same crypts appear morphologically normal in the early stages of tumourigenesis. 57 Aberrant crypt foci, which are putative precursor lesions for CRC, in rats treated with AOM and/or DSS are observed by surface examination of the luminal mucosa of colon preparations stained with methylene blue. 13, 58, 59 Furthermore, Schwitalla et al. have suggested that these theories need not exclude each other and that tumour-initiating mutations can occur in both normal stem cells and more differentiated cells, as long as both cells de-differentiate and re-acquire stem cell properties triggered by chronic inflammatory signalling. 60 They have demonstrated that epithelial non-stem cells can re-express stem cell markers and be converted into CSCs, and have provided an additional explanation of why patients with UC have an elevated risk of developing CRC. In neoplastic colon tumours from AOM/ DSS mice, pSmad2/3L-Thr-positive cells were present in very small numbers and were significantly detected around the tumour top. As expected in the tumours, immunohistochemical co-localisation of pSmad2/3L-Thr with β-catenin and CDK4 were observed, whereas co-localisation with Ki67 was not observed. In non-neoplastic and neoplastic epithelial cells, pSmad2/3L-Thr-positive cells have consistently indicated stem-like properties. There is a possibility that pSmad2/3L-Thr is a stem-like cell biomarker in other organs and in CSC. Future studies should try further to ascertain that pSmad2/3L-Thr-positive cells may be CSCs in neoplastic lesions.
We previously showed that TGF-β transmitted a signal through TGF-β type I receptor-dependent pSmad3C-Ser signalling, participating in the cytostatic response by repressing transcriptional activity of the c-myc gene. Proline-directed [Ras-associated] kinase-dependent pSmad2/3L-Ser signalling was able to provide carcinogenic potential to epithelial cells via up-regulation of c-myc, plasminogen activator inhibitor-1, and matrix metalloproteinases-1, -2, and -9, resulting in strongly enhanced tumour growth and invasion. 30, 31, 61 Taken together, domain-specific phosphorylation of Smad2 and Smad3 is a key determinant regulating transcriptional activation of several target genes, ultimately selecting either tumour suppression or carcinogenesis. In accordance with our previous investigations, the percentage of pSmad3L-Ser-positive cells in neoplastic colon tumours from AOM/ DSS mice was significantly increased compared with that in nonneoplastic epithelia from control and AOM/DSS mice. Furthermore, the percentage of pSmad3L-Ser-positive cells in pre-neoplastic colitis epithelia from AOM/DSS mice was significantly increased compared with normal epithelia from control mice. As for immunohistochemical staining of c-Myc, a small number of c-Myc-positive cells were observed in crypt bases in non-neoplastic colon epithelia in control mice, but many c-Myc-positive cells were observed throughout the tumours of AOM/DSS mice. In comparison with immunoreactivities of Ki67, β-catenin, cyclin D1, and Sox9, pSmad3L-Ser-immunoreactivity is the earliest carcinogenic event, observed even in the pre-neoplastic state of the mouse model of colitis-associated CRC.
In conclusion, pSmad3L-Ser signalling correlates with carcinogenesis of colon tumours from AOM/DSS mice [i.e. in colitis-associated CRC], and this work supports the hypothesis that pSmad2/3L-Thr immunostaining-positive cells are CSCs.
